Moore Kelli, Kunin Jeff, Alnijoumi Mohammed, Nagpal Prashant, Bhat Ambarish P
Department of Radiology, Section of Pulmonary and Critical Care, University of Missouri, Columbia, Missouri, United States.
Department of Medicine, Section of Pulmonary and Critical Care, University of Missouri, Columbia, Missouri, United States.
J Clin Imaging Sci. 2021 Jan 25;11:5. doi: 10.25259/JCIS_229_2020. eCollection 2021.
Acute pulmonary embolism (PE) is a significant cause of mortality and morbidity across the globe. Over the last few decades, there have been major therapeutic advances in acute PE management, including catheter-based therapy. However, the effectiveness of catheter-based therapy in acute PE is not supported by Level I evidence, making the use of this promising treatment rather controversial and ambiguous. In this paper, we discuss the risk stratification of acute PE and review the medical and endovascular treatment options. We also summarize and review the data supporting the use of endovascular treatment options in acute PE and describe the potential role of the PE response team.
急性肺栓塞（PE）是全球范围内导致死亡和发病的重要原因。在过去几十年中，急性PE的治疗取得了重大进展，包括基于导管的治疗。然而，基于导管的治疗在急性PE中的有效性缺乏一级证据支持，这使得这种有前景的治疗方法的应用颇具争议且不明确。在本文中，我们讨论急性PE的风险分层，并回顾药物和血管内治疗选择。我们还总结和回顾支持在急性PE中使用血管内治疗选择的数据，并描述PE反应团队的潜在作用。
